Shandong Pharmaceutical Glass Co Ltd Financial Flexibility Index
Shandong Pharmaceutical Glass Co Ltd financial flexibility index. Shandong Pharmaceutical Glass Co Ltd (600529) has a Financial Flexibility Index of 0.11x as of December 2025. Free cash flow of CN¥194.64 Million (operating CF CN¥41.46 Million minus capex CN¥153.18 Million) represents 0% of total liabilities (CN¥1.75 Billion). See Shandong Pharmaceutical Glass Co Ltd free cash flow efficiency to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Shandong Pharmaceutical Glass Co Ltd (2001–2025)
Financial flexibility index of Shandong Pharmaceutical Glass Co Ltd from 2001 to 2025. Historical Financial Flexibility Index trend for Shandong Pharmaceutical Glass Co Ltd across 25 annual periods. Check Shandong Pharmaceutical Glass Co Ltd earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Shandong Pharmaceutical Glass Co Ltd Financial Flexibility Index by Year (2001–2025)
Shandong Pharmaceutical Glass Co Ltd financial flexibility index by year from 2001 to 2025. Year-by-year free cash flow to debt coverage for Shandong Pharmaceutical Glass Co Ltd. For the full cash flow conversion analysis, see Shandong Pharmaceutical Glass Co Ltd cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.46x | CN¥808.79 Million | CN¥576.92 Million | CN¥1.75 Billion | ▼ -45.6% |
| 2024 | 0.85x | CN¥1.81 Billion | CN¥1.17 Billion | CN¥2.13 Billion | ▼ -11.8% |
| 2023 | 0.96x | CN¥1.72 Billion | CN¥1.05 Billion | CN¥1.78 Billion | ▲ +82.4% |
| 2022 | 0.53x | CN¥963.16 Million | CN¥252.44 Million | CN¥1.82 Billion | ▼ -41.1% |
| 2021 | 0.90x | CN¥1.56 Billion | CN¥750.44 Million | CN¥1.74 Billion | ▲ +11.2% |
| 2020 | 0.81x | CN¥1.10 Billion | CN¥566.01 Million | CN¥1.37 Billion | ▼ -11.8% |
| 2019 | 0.91x | CN¥1.19 Billion | CN¥599.05 Million | CN¥1.30 Billion | ▲ +23.4% |
| 2018 | 0.74x | CN¥813.16 Million | CN¥465.77 Million | CN¥1.10 Billion | ▲ +18.9% |
| 2017 | 0.62x | CN¥579.03 Million | CN¥411.96 Million | CN¥929.84 Million | ▼ -23.8% |
| 2016 | 0.82x | CN¥703.11 Million | CN¥506.53 Million | CN¥860.62 Million | ▲ +10.3% |
| 2015 | 0.74x | CN¥544.75 Million | CN¥389.63 Million | CN¥735.61 Million | ▲ +28.2% |
| 2014 | 0.58x | CN¥400.16 Million | CN¥266.63 Million | CN¥692.56 Million | ▼ -6.9% |
| 2013 | 0.62x | CN¥419.09 Million | CN¥268.60 Million | CN¥675.48 Million | ▲ +176.7% |
| 2012 | 0.22x | CN¥150.62 Million | CN¥28.52 Million | CN¥671.80 Million | ▼ -70.6% |
| 2011 | 0.76x | CN¥492.15 Million | CN¥274.63 Million | CN¥644.80 Million | ▲ +42.3% |
| 2010 | 0.54x | CN¥417.38 Million | CN¥217.01 Million | CN¥778.34 Million | ▼ -9.1% |
| 2009 | 0.59x | CN¥367.71 Million | CN¥249.27 Million | CN¥623.51 Million | ▲ +26.0% |
| 2008 | 0.47x | CN¥250.15 Million | CN¥91.76 Million | CN¥534.52 Million | ▼ -6.8% |
| 2007 | 0.50x | CN¥283.46 Million | CN¥122.63 Million | CN¥564.66 Million | ▲ +137.7% |
| 2006 | 0.21x | CN¥149.06 Million | CN¥78.47 Million | CN¥705.86 Million | ▼ -7.8% |
| 2005 | 0.23x | CN¥129.18 Million | CN¥44.09 Million | CN¥564.27 Million | ▼ -30.1% |
| 2004 | 0.33x | CN¥142.42 Million | CN¥-3.70 Million | CN¥434.85 Million | ▼ -69.3% |
| 2003 | 1.07x | CN¥331.09 Million | CN¥59.35 Million | CN¥310.80 Million | ▲ +40.9% |
| 2002 | 0.76x | CN¥221.75 Million | CN¥109.26 Million | CN¥293.28 Million | ▲ +240.6% |
| 2001 | 0.22x | CN¥53.92 Million | CN¥28.60 Million | CN¥242.90 Million | — |